Predictive Oncology Inc.
POAI
$1.06
-$0.03-2.75%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 611.60K | 345.70K | 278.70K | 419.60K | 319.60K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 611.60K | 345.70K | 278.70K | 419.60K | 319.60K |
| Cost of Revenue | 290.60K | 196.90K | 153.00K | 187.40K | 241.80K |
| Gross Profit | 321.00K | 148.80K | 125.80K | 232.20K | 77.80K |
| SG&A Expenses | 2.44M | 2.46M | 3.32M | 4.47M | 3.10M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.74M | 2.66M | 3.47M | 4.66M | 3.34M |
| Operating Income | -2.12M | -2.31M | -3.19M | -4.24M | -3.02M |
| Income Before Tax | -2.10M | -2.28M | -3.18M | -4.22M | -2.99M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -2.10M | -2.28M | -3.18M | -4.22M | -2.99M |
| Earnings from Discontinued Operations | -68.70K | -811.30K | -- | -- | -483.20K |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.17M | -3.09M | -3.18M | -4.22M | -3.48M |
| EBIT | -2.12M | -2.31M | -3.19M | -4.24M | -3.02M |
| EBITDA | -2.08M | -2.27M | -3.03M | -4.07M | -2.98M |
| EPS Basic | -0.33 | -0.48 | -0.68 | -1.04 | -0.86 |
| Normalized Basic EPS | -0.20 | -0.22 | -0.43 | -0.65 | -0.47 |
| EPS Diluted | -0.33 | -0.48 | -0.68 | -1.04 | -0.86 |
| Normalized Diluted EPS | -0.20 | -0.22 | -0.43 | -0.65 | -0.47 |
| Average Basic Shares Outstanding | 6.68M | 6.40M | 4.66M | 4.06M | 4.06M |
| Average Diluted Shares Outstanding | 6.68M | 6.40M | 4.66M | 4.06M | 4.06M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |